| scholarly article | Q13442814 |
| P2093 | author name string | Osamu Shimozato | |
| Masako Chiyo | |||
| Ling Yu | |||
| Takehiko Fujisawa | |||
| Toshihiko Iizasa | |||
| Masatoshi Tagawa | |||
| Kiyoko Kawamura | |||
| P2860 | cites work | Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment | Q24301442 |
| WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27 | Q24307411 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 437-442 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. | |
| P478 | volume | 115 |
| Q50915108 | A Polyglutamic Acid Motif Confers IL-27 Hydroxyapatite and Bone-Binding Properties |
| Q37747078 | A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes |
| Q33967201 | Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1. |
| Q40814716 | Administration of DNA Encoding the Interleukin-27 Gene Augments Antitumour Responses through Non-adaptive Immunity |
| Q37124028 | Advances in understanding the anti-inflammatory properties of IL-27. |
| Q39176967 | Antitumor effects obtained by autologous Lewis lung cancer cell vaccine engineered to secrete mouse Interleukin 27 by means of cationic liposome |
| Q53216723 | Association between polymorphisms in IL27 gene and renal cell carcinoma. |
| Q36010208 | Association of 3 Common Polymorphisms of IL-27 Gene with Susceptibility to Cancer in Chinese: Evidence From an Updated Meta-Analysis of 27 Studies |
| Q55460805 | Association of IL-27 polymorphisms and cancer risk in Chinese population. |
| Q82274685 | Association of single nucleotide polymorphisms in IL-12 and IL-27 genes with colorectal cancer risk |
| Q47444633 | Associations between polymorphisms in IL-12A, IL-12B, IL-12Rβ1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer |
| Q36218965 | Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway |
| Q40779943 | Current Research of the Roles of IL-35 in Tumor Progression |
| Q59329184 | Distinct Role of IL-27 in Immature and LPS-Induced Mature Dendritic Cell-Mediated Development of CD4 CD1273G11 Regulatory T Cell Subset |
| Q36928203 | Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway |
| Q35018373 | Expression of IL-27 by tumor cells in invasive cutaneous and metastatic melanomas [corrected].. |
| Q39834167 | Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance |
| Q39094179 | Genetic association between IL-27 rs153109 polymorphism and cancer risk in Chinese population: a meta-analysis |
| Q33801032 | High Interleukin 27 Production is Associated with Early Clinical Stage and Localized Disease in Patients with Melanoma |
| Q33670036 | IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. |
| Q35025256 | IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner |
| Q38073078 | IL-27 in tumor immunity and immunotherapy |
| Q36685395 | IL-27 induces the expression of IDO and PD-L1 in human cancer cells |
| Q37532498 | IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer |
| Q34581324 | IL-27 is required for shaping the magnitude, affinity distribution, and memory of T cells responding to subunit immunization |
| Q44868708 | IL-27 promotes nitric oxide production induced by LPS through STAT1, NF-κB and MAPKs |
| Q89928899 | IL-27p28 Production by XCR1+ Dendritic Cells and Monocytes Effectively Predicts Adjuvant-Elicited CD8+ T Cell Responses |
| Q42056219 | IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skin |
| Q83694265 | IL‐27 induction of IL‐21 from human CD8+ T cells induces granzyme B in an autocrine manner |
| Q85746486 | IL‐32γ enhances TNF‐α‐induced cell death in colon cancer |
| Q37315226 | Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow |
| Q36724827 | Immunotherapy of cancer by IL-12-based cytokine combinations |
| Q37607910 | Interleukin 27: a double-edged sword for offense and defense |
| Q37668153 | Interleukin-27 Enhances the Potential of Reactive Oxygen Species Generation from Monocyte-derived Macrophages and Dendritic cells by Induction of p47phox |
| Q39666166 | Interleukin-27 acts on hepatic stellate cells and induces signal transducer and activator of transcription 1-dependent responses |
| Q38850577 | Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis |
| Q35868095 | Interleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses |
| Q37202267 | Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. |
| Q36627497 | Interleukin-27 rs153109 polymorphism and the risk of non-small-cell lung cancer in a Chinese population |
| Q34647840 | Interleukin-27 signaling promotes immunity against endogenously arising murine tumors |
| Q26830400 | Interleukin-27: Balancing Protective and Pathological Immunity |
| Q37773302 | Interleukins and cancer immunotherapy. |
| Q43693626 | Interleukin‐27 enhances the production of tumour necrosis factor‐α and interferon‐γ by bone marrow T lymphocytes in aplastic anaemia |
| Q42144816 | Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo |
| Q36585832 | Maintenance of CMV-specific CD8+ T cell responses and the relationship of IL-27 to IFN-γ levels with aging |
| Q36184396 | New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions |
| Q33508227 | Non-redundant role for IL-12 and IL-27 in modulating Th2 polarization of carcinoembryonic antigen specific CD4 T cells from pancreatic cancer patients |
| Q36684485 | Overview of tumor cell-based vaccines |
| Q34483131 | Potential clinical application of interleukin-27 as an antitumor agent |
| Q86976224 | Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population |
| Q37235449 | Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation. |
| Q40508641 | Regulation and Immune Function of IL-27. |
| Q36228914 | Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways |
| Q37592689 | Regulation of NK Cell Activation and Effector Functions by the IL-12 Family of Cytokines: The Case of IL-27. |
| Q37795583 | Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. |
| Q36394974 | Regulation of cytokine production during phagocytosis of apoptotic cells |
| Q35166971 | The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy |
| Q34786440 | The antitumor potential of Interleukin-27 in prostate cancer |
| Q36733744 | The biology and therapeutic potential of interleukin 27. |
| Q37099883 | The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte response |
| Q39796152 | The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses |
| Q41918691 | Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses |
| Q34647584 | Tumor-Derived IL-35 Promotes Tumor Growth by Enhancing Myeloid Cell Accumulation and Angiogenesis |
| Q37598465 | Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression |
| Q38011914 | Using mice to unveil the genetics of cancer resistance |
| Q34170074 | Vaccines and immunotherapeutics for the treatment of malignant disease |
| Q33895262 | WSX1 Expression in Tumors Induces Immune Tolerance via Suppression of Effector Immune Cells |
Search more.